$ENVA

RICE LINDA JOHNSON sold $210K of ENVA

RICE LINDA JOHNSON sold 1,300 shares of Enova International, Inc. (ENVA) at $161.20 ($0.21M total) on 2026-05-29.

Original reporting
SEC EDGAR · RICE LINDA JOHNSON
Published Jun 2, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 9:09 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ENVA
Neutral
medium confidence
Mentioned
$ENVA
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ENVANeutralLow
01

Why it matters

A director’s open-market sale is disclosed, but the text contains no new company performance, guidance, or regulatory development.

02

Market read

Traders may note the insider sale for sentiment, but there is no fundamental catalyst in the text.

03

What to watch

The article does not state whether other insiders sold/bought, whether there were option exercises, or whether the sale was part of a broader pattern.

Relevance 4/10Novelty 3/10Timing: SEC Form 4 filed 2026-06-02 for a sale dated 2026-05-29.

Background

The article is an SEC Form 4 insider transaction disclosure for Enova International, Inc.

Company-level read

Ticker impact

$ENVANeutralMedium confidence
Context

Director Rice Linda Johnson filed a Form 4 open-market sale of 1,300 ENVA shares at $161.1968 on 2026-05-29.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven and typically fades unless paired with other disclosures.

Evidence & confidence

The filing is primary-source and time-stamped, but the article provides only a single sale transaction size and no accompanying guidance, operational update, or enforcement/regulatory event.

Market effects

No sector read-through is provided beyond a single insider transaction.

None indicated.

None indicated.

Counterpoint

Insider sales can be driven by diversification, taxes, or pre-planned liquidity needs, so this may not reflect bearish fundamentals.

Key entities

  • Enova International, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • RICE LINDA JOHNSON

    Director who sold 1,300 shares in an open-market transaction.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ENVAMedAI 8/10

Enova International subsidiary announces $500 million asset-backed notes offering

Enova International's subsidiary plans a $500M asset-backed notes offering, with four classes of notes ranging from 5.61% to 8.28% interest. The notes are backed by small business loans and expected to be rated by Kroll. Enova reported strong Q2 2026 earnings, exceeding estimates, but withdrew a bank acquisition due to regulatory challenges. Citizens lowered its price target to $215, maintaining an Outperform rating.

$ENVAMedAI 8/10

Enova to issue $500.026M Series 2026-1 asset-backed notes backed by OnDeck loans

Enova plans to issue $500.026M in asset-backed notes due 2026, secured by OnDeck small business loans. The notes, divided into four classes, have fixed rates ranging from 5.61% to 8.28%. KBRA is expected to rate the notes AA(sf) to BB(sf). The proceeds will be used to purchase loans from OnDeck and fund a reserve account. The offering is targeted at qualified institutional buyers under Rule 144A and offshore under Regulation S, with a closing date around September 25, 2026, subject to conditions